Angie Risley Acquires 1,601 Shares of Smith & Nephew plc (SN) Stock

Smith & Nephew plc (LON:SN) insider Angie Risley bought 1,601 shares of the stock in a transaction on Friday, February 9th. The stock was purchased at an average cost of GBX 1,249 ($17.51) per share, with a total value of £19,996.49 ($28,037.70).

Shares of Smith & Nephew plc (SN) traded down GBX 2 ($0.03) during mid-day trading on Friday, reaching GBX 1,226 ($17.19). 2,782,390 shares of the company’s stock were exchanged, compared to its average volume of 2,760,000. The firm has a market cap of $10,890.00 and a price-to-earnings ratio of 1,946.03. Smith & Nephew plc has a 52-week low of GBX 1,143 ($16.03) and a 52-week high of GBX 1,442 ($20.22).

A number of brokerages have weighed in on SN. JPMorgan Chase & Co. upgraded shares of Smith & Nephew to an “overweight” rating and lifted their price target for the company from GBX 1,369 ($19.20) to GBX 1,411 ($19.78) in a report on Thursday, January 25th. Jefferies Group reiterated a “buy” rating and issued a GBX 1,515 ($21.24) price target on shares of Smith & Nephew in a report on Monday, November 6th. Citigroup reiterated a “sell” rating and issued a GBX 1,160 ($16.26) price target on shares of Smith & Nephew in a report on Thursday, October 12th. Deutsche Bank restated a “buy” rating on shares of Smith & Nephew in a report on Friday, October 13th. Finally, Credit Suisse Group lifted their target price on shares of Smith & Nephew from GBX 1,285 ($18.02) to GBX 1,290 ($18.09) and gave the company a “neutral” rating in a report on Friday. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of GBX 1,320.55 ($18.52).

TRADEMARK VIOLATION WARNING: “Angie Risley Acquires 1,601 Shares of Smith & Nephew plc (SN) Stock” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/02/09/angie-risley-acquires-1601-shares-of-smith-nephew-plc-sn-stock.html.

Smith & Nephew Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply